EPO
Also known as Erythropoietin, Epoetin
A glycoprotein hormone that stimulates red blood cell production, used clinically for specific anemia indications and tightly controlled because of thrombotic and doping risks.
Overview
EPO is erythropoietin, a glycoprotein hormone that stimulates red blood cell production. It is a regulated medicine in specific anemia contexts and a major anti-doping concern in sport.
The Science
EPO acts on erythroid progenitor cells in bone marrow, increasing red blood cell production when clinically appropriate.
- Anemia medicine - chronic kidney disease and selected treatment-related anemia contexts.
- Oxygen transport - increased red cell mass changes oxygen-carrying capacity.
- Risk profile - excessive erythropoiesis can increase blood viscosity and thrombotic risk.
Evidence Snapshot
EPO is clinically powerful and medically useful in the right context. It is not a wellness peptide, and use outside monitored indications carries serious risk.
Related
More in Healing & Recovery
ARA-290
InvestigationalHealing & Recovery
An erythropoietin-derived peptide studied for tissue-protective and anti-inflammatory signaling without the red-blood-cell stimulation associated with EPO.
Botulinum Toxin
FDA-approvedHealing & Recovery
Not a peptideProtein toxin
A bacterial neurotoxin protein used clinically in tightly controlled doses for neuromuscular, migraine, autonomic, and cosmetic indications; it is not a peptide supplement.
BPC-157
Research compoundHealing & Recovery
A stable 15-amino-acid peptide fragment derived from a protein in human gastric juice, widely studied in preclinical models for tissue protection and repair across gut, tendon, muscle, and vascular tissue.